Trusted Resources: People & Places
Online groups, photo galleries and blogs
CHOP – Lysosomal Storage Disease (LSD) Center
3401 Civic Center Blvd.Philadelphia, Pennsylvania, United States
Phone Web
The Lysosomal Storage Disease Center at Children’s Hospital of Philadelphia (CHOP) provides comprehensive testing, treatment and management for children, adolescents and young adults with a diagnosis or suspected diagnosis of lysosomal storage diseases (LSD) like Mucopolysaccharidosis.
Treatment for LSDs includes enzyme replacement therapy and bone marrow transplants to maximize patient outcomes. At CHOP’s LSD Center, we work with families to coordinate services across a therapeutic team.
Why Choose Us?
The Lysosomal Storage Disease Center combines excellent clinical care with access to active clinical research and new drug trials for patients interested in participating. Our team has been involved in LSD diagnosis and management for more than 20 years and has been recognized as a center for excellence. Our multidisciplinary clinics are devoted to our patients and aim to improve patient outcomes and satisfaction.
Conditions We Treat:
• Mucopolysaccharidosis Type 1
• Mucopolysaccharidosis Type II
BookmarkRelated Content
-
Understanding How Enzymes Work and Affect Our Bodyhttps://slideplayer.com/slide/7566393/...
-
Hunter Syndrome – After Diagnosis: What Next?Talking About the Diagnosis It can be ha...
-
Treatment of Skeletal and Non-Skeletal Alterations of Mucopolysaccharidosis Type IVA by AAV-Mediated Gene TherapyMucopolysaccharidosis type IVA (MPSIVA) ...
-
Impact of the COVID-19 Pandemic on the Standard of Care for Patients With Lysosomal Storage Diseases: A Survey of He...The impact of the COVID-19 pandemic on t...
-
Inhibition of Iduronic Acid Biosynthesis by Ebselen Reduces Glycosaminoglycan Accumulation in Mucopolysaccharidosis ...Mucopolysaccharidosis type I (MPS-I) is ...
-
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysacc...AVROBIO, Inc., a leading clinical-stage ...
-
Enzyme Replacement Therapy With Galsulfase for Mucopolysaccharidosis Type VIMucopolysaccharidosis type VI (MPS VI) o...
